Close Menu

NEW YORK – SolGent said on Thursday that it has received the CE mark for its DiaPlexQ Novel Coronavirus (2019-nCoV) Detection assay, as well as authorization from regulatory authorities in Korea and the Philippines.

The company's test qualitatively detects the Orf1a and N genes of the novel coronavirus in sputum, oropharyngeal, and nasopharyngeal specimens from patients with suspected respiratory infection.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.